These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7102649)

  • 1. An epidemiologic study of hip fracture in postmenopausal women.
    Kreiger N; Kelsey JL; Holford TR; O'Connor T
    Am J Epidemiol; 1982 Jul; 116(1):141-8. PubMed ID: 7102649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study.
    Kiel DP; Felson DT; Anderson JJ; Wilson PW; Moskowitz MA
    N Engl J Med; 1987 Nov; 317(19):1169-74. PubMed ID: 3657888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of hip fracture in postmenopausal females with or without estrogen drug exposure.
    Johnson RE; Specht EE
    Am J Public Health; 1981 Feb; 71(2):138-44. PubMed ID: 7457682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen.
    Weiss NS; Ure CL; Ballard JH; Williams AR; Daling JR
    N Engl J Med; 1980 Nov; 303(21):1195-8. PubMed ID: 7421945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproductive history and postmenopausal risk of hip and forearm fracture.
    Alderman BW; Weiss NS; Daling JR; Ure CL; Ballard JH
    Am J Epidemiol; 1986 Aug; 124(2):262-7. PubMed ID: 3728442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study.
    Hutchinson TA; Polansky SM; Feinstein AR
    Lancet; 1979 Oct; 2(8145):705-9. PubMed ID: 90802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of low potency estrogens does not reduce the risk of hip fracture.
    Michaëlsson K; Baron JA; Farahmand BY; Ljunghall S
    Bone; 2002 Apr; 30(4):613-8. PubMed ID: 11934654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteoporosis Risk Assessment.
    Yates J; Barrett-Connor E; Barlas S; Chen YT; Miller PD; Siris ES
    Obstet Gynecol; 2004 Mar; 103(3):440-6. PubMed ID: 14990403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total and free estrogens and androgens in postmenopausal women with hip fractures.
    Davidson BJ; Ross RK; Paganini-Hill A; Hammond GD; Siiteri PK; Judd HL
    J Clin Endocrinol Metab; 1982 Jan; 54(1):115-20. PubMed ID: 7198650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menopausal estrogen therapy and hip fractures.
    Paganini-Hill A; Ross RK; Gerkins VR; Henderson BE; Arthur M; Mack TM
    Ann Intern Med; 1981 Jul; 95(1):28-31. PubMed ID: 7247123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Past and recent physical activity and risk of hip fracture.
    Jaglal SB; Kreiger N; Darlington G
    Am J Epidemiol; 1993 Jul; 138(2):107-18. PubMed ID: 8342529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and the risk for first hip fracture. A prospective, population-based cohort study.
    Naessén T; Persson I; Adami HO; Bergström R; Bergkvist L
    Ann Intern Med; 1990 Jul; 113(2):95-103. PubMed ID: 2360759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of hip fractures and methods of prevention.
    Armstrong AL; Wallace WA
    Acta Orthop Belg; 1994; 60 Suppl 1():85-101. PubMed ID: 8053345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breastfeeding and other reproductive factors and the risk of hip fractures in elderly women.
    Cumming RG; Klineberg RJ
    Int J Epidemiol; 1993 Aug; 22(4):684-91. PubMed ID: 8225744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of menopausal effect on hip fracture occurrence in white females.
    Brody JA; Farmer ME; White LR
    Am J Public Health; 1984 Dec; 74(12):1397-8. PubMed ID: 6507694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of postmenopausal hip fracture in Mexican American women.
    Bauer RL; Diehl AK; Barton SA; Brender J; Deyo RA
    Am J Public Health; 1986 Aug; 76(8):1020-1. PubMed ID: 3728760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased incidence of hip fracture in osteoporotic women treated with sodium fluoride.
    Hedlund LR; Gallagher JC
    J Bone Miner Res; 1989 Apr; 4(2):223-5. PubMed ID: 2728925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of weight, smoking, and estrogen use on the risk of hip and forearm fractures in postmenopausal women.
    Williams AR; Weiss NS; Ure CL; Ballard J; Daling JR
    Obstet Gynecol; 1982 Dec; 60(6):695-9. PubMed ID: 7145267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abdominal fat and hip fracture risk in the elderly: the Dubbo Osteoporosis Epidemiology Study.
    Nguyen ND; Pongchaiyakul C; Center JR; Eisman JA; Nguyen TV
    BMC Musculoskelet Disord; 2005 Feb; 6():11. PubMed ID: 15727686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthropometric indicators and hip fracture. The NHANES I epidemiologic follow-up study.
    Farmer ME; Harris T; Madans JH; Wallace RB; Cornoni-Huntley J; White LR
    J Am Geriatr Soc; 1989 Jan; 37(1):9-16. PubMed ID: 2909610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.